127 related articles for article (PubMed ID: 36353988)
1. Ex Vivo Modeling of the PC (Protein C) Pathway Using Endothelial Cells and Plasma: A Personalized Approach.
Schwarz N; Müller J; Yadegari H; McRae HL; Reda S; Hamedani NS; Oldenburg J; Pötzsch B; Rühl H
Arterioscler Thromb Vasc Biol; 2023 Jan; 43(1):109-119. PubMed ID: 36353988
[TBL] [Abstract][Full Text] [Related]
2. Increased Activated Protein C Response Rates Reduce the Thrombotic Risk of Factor V Leiden Carriers But Not of Prothrombin 20210G>A Carriers.
Rühl H; Berens C; Winterhagen FI; Reda S; Müller J; Oldenburg J; Pötzsch B
Circ Res; 2019 Aug; 125(5):523-534. PubMed ID: 31314700
[TBL] [Abstract][Full Text] [Related]
3. The procoagulant effects of factor V Leiden may be balanced against decreased levels of factor V and do not reflect in vivo thrombin formation in newborns.
Hyytiäinen S; Wartiovaara-Kautto U; Ulander VM; Kaaja R; Heikinheimo M; Petäjä J
Thromb Haemost; 2006 Mar; 95(3):434-40. PubMed ID: 16525570
[TBL] [Abstract][Full Text] [Related]
4. Role of Gly197 in the structure and function of protein C.
Lu Y; Biswas I; Villoutreix BO; Rezaie AR
Biochim Biophys Acta Gen Subj; 2021 Jun; 1865(6):129892. PubMed ID: 33722640
[TBL] [Abstract][Full Text] [Related]
5. Thrombomodulin-mediated catabolism of protein C by pleural mesothelial and vascular endothelial cells.
Iakhiaev AV; Rezaie AR; Idell S
Thromb Haemost; 2007 Sep; 98(3):627-34. PubMed ID: 17849052
[TBL] [Abstract][Full Text] [Related]
6. Tissue factor up-regulation in proinflammatory conditions confers thrombin generation capacity to endothelial colony-forming cells without influencing non-coagulant properties in vitro.
Cuccuini W; Poitevin S; Poitevin G; Dignat-George F; Cornillet-Lefebvre P; Sabatier F; Nguyen P
J Thromb Haemost; 2010 Sep; 8(9):2042-52. PubMed ID: 20546120
[TBL] [Abstract][Full Text] [Related]
7. The Gla26 residue of protein C is required for the binding of protein C to thrombomodulin and endothelial cell protein C receptor, but not to protein S and factor Va.
Nishioka J; Ido M; Hayashi T; Suzuki K
Thromb Haemost; 1996 Feb; 75(2):275-82. PubMed ID: 8815576
[TBL] [Abstract][Full Text] [Related]
8. Modulation of the activated protein C pathway in severe haemophilia A patients: The effects of thrombomodulin and a factor V-stabilizing fab.
Brophy DF; Martin EJ; Mohammed BM; Barrett JC; Kuhn JG; Nolte ME; Wiinberg B; Holmberg HL; Lund J; Salbo R; Waters EK
Haemophilia; 2017 Nov; 23(6):941-947. PubMed ID: 28750471
[TBL] [Abstract][Full Text] [Related]
9. Covalent antithrombin-heparin effect on thrombin-thrombomodulin and activated protein C reaction with factor V/Va.
Van Walderveen MC; Berry LR; Atkinson HM; Chan AK
Thromb Haemost; 2010 May; 103(5):910-9. PubMed ID: 20216984
[TBL] [Abstract][Full Text] [Related]
10. Occupancy of human EPCR by protein C induces β-arrestin-2 biased PAR1 signaling by both APC and thrombin.
Roy RV; Ardeshirylajimi A; Dinarvand P; Yang L; Rezaie AR
Blood; 2016 Oct; 128(14):1884-1893. PubMed ID: 27561318
[TBL] [Abstract][Full Text] [Related]
11. The effect of aprotinin on activated protein C-mediated downregulation of endogenous thrombin generation.
Tanaka KA; Szlam F; Levy JH
Br J Haematol; 2006 Jul; 134(1):77-82. PubMed ID: 16803571
[TBL] [Abstract][Full Text] [Related]
12. The impact of the endothelial protein C receptor on thrombin generation and clot lysis.
Pepler L; Wu C; Dwivedi DJ; Wu C; Kim PY; Liaw PC
Thromb Res; 2017 Apr; 152():30-37. PubMed ID: 28219843
[TBL] [Abstract][Full Text] [Related]
13. Inherited abnormalities in the protein C activation pathway.
España F; Medina P; Navarro S; Estellés A; Aznar J
Pathophysiol Haemost Thromb; 2002; 32(5-6):241-4. PubMed ID: 13679649
[TBL] [Abstract][Full Text] [Related]
14. Monitoring of plasma levels of activated protein C using a clinically applicable oligonucleotide-based enzyme capture assay.
Müller J; Friedrich M; Becher T; Braunstein J; Kupper T; Berdel P; Gravius S; Rohrbach F; Oldenburg J; Mayer G; Pötzsch B
J Thromb Haemost; 2012 Mar; 10(3):390-8. PubMed ID: 22236082
[TBL] [Abstract][Full Text] [Related]
15. Protein C activation and factor Va inactivation on human umbilical vein endothelial cells.
Hockin MF; Kalafatis M; Shatos M; Mann KG
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2765-75. PubMed ID: 9409254
[TBL] [Abstract][Full Text] [Related]
16. Probing the activation of protein C by the thrombin-thrombomodulin complex using structural analysis, site-directed mutagenesis, and computer modeling.
Knobe KE; Berntsdotter A; Shen L; Morser J; Dahlbäck B; Villoutreix BO
Proteins; 1999 May; 35(2):218-34. PubMed ID: 10223294
[TBL] [Abstract][Full Text] [Related]
17. Protective signaling by activated protein C is mechanistically linked to protein C activation on endothelial cells.
Feistritzer C; Schuepbach RA; Mosnier LO; Bush LA; Di Cera E; Griffin JH; Riewald M
J Biol Chem; 2006 Jul; 281(29):20077-84. PubMed ID: 16709569
[TBL] [Abstract][Full Text] [Related]
18. Platelet factor 4 enhances generation of activated protein C in vitro and in vivo.
Slungaard A; Fernandez JA; Griffin JH; Key NS; Long JR; Piegors DJ; Lentz SR
Blood; 2003 Jul; 102(1):146-51. PubMed ID: 12609838
[TBL] [Abstract][Full Text] [Related]
19. Thrombin spatial distribution determines protein C activation during hemostasis and thrombosis.
Marar TT; Matzko CN; Wu J; Esmon CT; Sinno T; Brass LF; Stalker TJ; Tomaiuolo M
Blood; 2022 Mar; 139(12):1892-1902. PubMed ID: 34890454
[TBL] [Abstract][Full Text] [Related]
20. Fibrinolysis biomarker, thrombin, and activated protein C level alterations after coagulation activation depend on type of thrombophilia and clinical phenotype.
Reda S; Schwarz N; Müller J; McRae HL; Oldenburg J; Pötzsch B; Rühl H
Res Pract Thromb Haemost; 2024 Feb; 8(2):102351. PubMed ID: 38487678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
